Module 2

Opioid Use Disorder

The College of Medicine, CME, and USask Continuing Pharmacy Education (CPE) have launched a new program called Advancing Interprofessional Management of Substance Use Disorders in Saskatchewan ( AIMS-SK). The AIMS-SK program is designed to improve health outcomes for individuals with substance use disorders.

Target Audience:

The target audience is Physicians, Pharmacists, Nurse Practitioners, Nurses, Dentists, Social Workers, Addiction Counsellors, and other healthcare professionals are encouraged to attend.

Module 2 Learning Objectives:

At the end of this module, participants will be able to:

Summarize the ‘College of Physicians and Surgeons of Saskatchewan Opioid Agonist Therapy Program Standards and Guidelines’ including educational requirements and program restrictions.
Outline the ‘Saskatchewan Registered Nurses Association Nurse Practitioner Controlled Drugs and Substances Prescribing Guidelines’ for prescribing opioid use disorder medications.
Properly assess patients with opioid use disorder.
Differentiate between different opioid agonist therapies, including prescribing requirements and the different approaches to initiation.
Appropriately use drug screening to optimize treatment for patients.
Compare the pros and cons of opioid agonist therapy carries.
Understand the role of the pharmacist in opioid agonist therapy.
Describe the use of opioid agonist therapy in pregnancy and breastfeeding.
Summarize lessons learned from experienced opioid agonist therapy prescribers.